Anbio Biotechnology Class A Ordinary Shares
NNNNNASDAQ
Healthcare
$26.04
+0.33(1.28%)
Mkt Cap $1.1B
$6.10
$52.10
52-Week Range
At A Glance
1
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.
2
Most recently: Current Report on Form 6-K (2026-02-17).
$1.1B
Market Cap
$8M
Revenue
$3M
Net Income
Employees27
Fundamentals
How The Business Makes Money
Revenue by Geography
European Union79.6%($31M)
Asia Pacific9.8%($4M)
South America8.1%($3M)
Other Regions1.5%($583.4K)
North America1%($375.9K)
Activity
Company Profile
CIK0001982708
ISINKYG0367B1059
CUSIPG0367B105
Phone49 16 0962 47281
AddressWilhelm Gutbrod Str 21B, Frankfurt am Main, 60437, DE
SEC EDGAR